Actively personalized vaccination trial for newly diagnosed glioblastoma
2018 · Nature · 897 citations
https://doi.org/10.1038/s41586-018-0810-y
V
Valesca Bukur
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
4.3K
Citations
10
h-index
11
i10-index
Valesca Bukur is an academic researcher from Johannes Gutenberg University Mainz. The author has contributed to research in topics: Immunotherapy and Immune Responses & RNA Interference and Gene Delivery & Cancer Immunotherapy and Biomarkers. The author has an h-index of 10, co-authored 26 publications.
Papers by this author
worksNFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells
2016 · Nature Communications · 66 citations
https://doi.org/10.1038/ncomms11724
Development of a microfluidic based system for the enrichment and single cell analysis of circulating tumor cells (CTCs), project part TRON gGmbH
2016 · Open MIND · 0 citations
Ci3: Identifizierung und Entwicklung von Biomarkern für die individuelle Immunantwort auf L-BLP25/STIMUVAX, ein therapeutisches Krebsvakzin
2017 · Open MIND · 0 citations
IVAC - Individualisierte Vakzine zur Therapie des malignen Melanoms, Teilprojekt TRON
2016 · Open MIND · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat